Mike Sison

“I cover the ever-exciting chemical industry, which actually has outperformed over the last year to date, about 14%. S&P was up about 8%. FMC stock has struggled a little bit, down 15% year to date, and well off its decade high of over $100.”

“I cover the ever-exciting chemical industry for the company, which has outperformed the S&P 500. You know, our coverage universe is up 14% year-to-date versus the S&P 500 up 8%.”

“Just when you think about phosphate volumes and 2Q, you gave us guidance for that. If nothing really changes, is that sort of the level-based case we should think about for the third quarter?”

“Well, when you think about 2Q, the $160 to $200 million, how would you sort of describe the earnings levels? Are we approaching a mid-cycle sort of number? You know, it doesn't feel like peak, particularly on volume.”

“For chemical intermediates, can you give us some thoughts what pricing needs to be year-over-year in 2Q to get to the $50 million? And I'm just curious on the delta there in terms of the improvement year-over-year.”